News & Events

featured

BioLamina appoints Brian Hawkins, PhD as new Chief Technology Officer (CTO).

Stockholm, March 3, 2025 BioLamina appoints Brian Hawkins, PhD, as new Chief Technology Officer (CTO). BioLamina AB, appoints Brian Hawkins as Chief […]

featured

Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx

Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx We are proud to have been chosen by PluriStyx as their […]

events

Webinar: Treating Blindness with Stem Cell Therapies

How close are we to one-shot stem cell therapies for eye disease? What are the critical factors for successful translation to the […]